GET THE APP

Inner Banner image

Be a part of International Conference on Virology and Immunology

About Us

Date

June 15-16, 2022 at 09:00 AM GMT 
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Location

Vancouver, Canada

We are delighted to announce our upcoming International Conference on Virology &Immunology invites you with regards to the aim on research, innovation, and scientific aspects. The conference is going to be held at Vancouver, Canada on June 15-16, 2022. The theme of the conference is “Exploring recent outbreaks, advanced technologies in treatment & research of infectious diseases”.

Virology 2022 is a global platform for Pathologists, virologist, industry professionals, marketing professionals and researchers, scientists, clinicians, academics, students, Liver oncologists, Surgeons, Research scholars and other healthcare professionals. The primary goal of the conference is to promote the latest advancements, research and developments, explore the challenges in Virology and Bacteriology related areas and share innovations, research, and ideas on pathology for a greater development and more effective treatments.

Session 1: Medical Virology and Parasitology
Medical parasitology traditionally has included the study of three major groups of animals: parasitic protozoa, parasitic helminthic (worms), and those arthropods that directly cause disease or act as vectors of various pathogens. A parasite is a pathogen that simultaneously injures and derives sustenance from its host. Some organisms called parasites are actually commensals, in that they neither benefit nor harm their host (for example, Endamoeba coli). Infections of humans caused by parasites number in the billions and range from relatively innocuous to fatal.
Medical Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress
Session 2: Molecular Biology Research and Viral Therapy
Molecular biology is most advance form of research field to detect the infection by going through the molecular composition of virus. Molecular therapy   includes various types of techniques such as DNA cloning, proliferation of DNA, bacterial transformation, transfection, etc. Most important techniques are polymerase chain reaction (PCR), Southern blotting, and Northern blotting. Viral therapy for cancer, also called oncolytic viral therapy. Oncolytic viral therapy can be use for the treatment of pancreatic cancer or pancreas cancer.      Molecular Biology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress
Session 3: Plant Viral Infection and Prevention
Many plant pathogens, particularly fungi, can be controlled by the application of chemicals which interfere in some way with the metabolism of the invading pathogen, and so prevent or ameliorate disease. Unfortunately, these methods cannot be used so extensively to control plant viruses. Having few, if any, enzymes of their own, viruses depend either on enzymes already in host cells or on those that are induced as a result of infection. These enzymes are responsible for nucleic acid and protein synthesis, and chemical interruption of their activity disrupts similar enzymes essential for the normal functioning of cells. Prevention, or at least alleviation, of the effects of viruses, involves :
  • Control of vectors.
  • Breeding for resistance and the use of cross-protection methods. Each of these approaches to control will be considered
  • Elimination of sources of virus.
  • Elimination of the virus from infected plants.
Session 4: Veterinary Virology
Viruses are smaller and simpler in construction than unicellular microorganisms, and they contain only one type of nucleic acid—either DNA or RNA—never both. As viruses have no ribosomes, mitochondria, or other organelles, they are completely dependent on their cellular hosts for energy production and protein synthesis. They replicate only within cells of the host that they infect. Animal virology developed largely from the need to control viral diseases in humans and their domesticated animals. Viruses, like other infectious agents, enter the animal body through one of its surfaces. They then spread either locally on one of the body surfaces or through lymphatic and blood vessels to produce systemic infection.
Veterinary Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress
Session 5: Clinical and Diagnostic Virology
Diagnosis of any probable viral infection with the help of various tests such as, specific, assorted or conventional tests to identify the causative virus. Multiple methods are in use for laboratory diagnosis in probing the viral infections, including serology, viral culture, antigen detection, and nucleic acid detection. Due to various developments in the technology, we see high-end and quite impressive immunologic and molecular diagnostic tests are developed to provide more accurate results and to detect the viruses- type, number and to identify their pathogenicity as well. This field provides specific recommendations for diagnostic approach to clinically important viral infections.
Clinical Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress
Session 6: Covid-19 Infection, Prevention and Control
The most number of affected pregnant women is increasing, but scarce information is available about the clinical features Obstetrics Infections outcomes of pregnant patients with COVID-19 in pregnancy caused by severe acute respiratory syndrome coronavirus Moreover maternal, fatal, and neonatal outcomes of patients who were infected in late pregnancy appeared very good, and these outcomes were achieved with intensive, active management that might be the best practice in the absence of more robust data.
The clinical characteristics of these patients with COVID-19 during pregnancy were similar to those of non-pregnant adults with COVID-19 clinical symptoms from 33 Infections with or at risk of COVID-19 were mild and outcomes were favourable of the 3 neonates with symptomatic COVID-19, presented with early-onset SARS-CoV-2 infection.
Covid-19 Virus Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress
Session 7: Ebola, Marburg Viruses and Zika Virus
Zika virus typically leads to mild febrile cases, with most being asymptomatic, Ebola has severe symptoms. They are an animal origin in other words, a zoonoses. Ebola has high mortality rate Zika virus not. The Ebola can only be transmitted when symptoms are present.“Outbreak” is a term referring to a virus or a parasite that is transmitted very aggressively and therefore could potentially cause fatalities, as the recent Ebola and Zika epidemics did. Nevertheless, looking back through history, quite a few outbreaks have been reported, which turned out so deadly that essentially changed, molded and literally re-shaped the society as it is today
Virology Conference | Virology Congress | Immunology Conference | Virology and Immunology Conference | Upcoming Virology Congress
Session 8: HIV and STDs
HIV and STDs are the simultaneous infections of a host by multiple pathogen species. There are different co-infections that are associated with STD especially with HIV which leads to lethal condition and worsens the condition of the individual. Co-infection is of particular human health importance because these pathogen species can interact within the host. The net effect of the co-infection on human health is thought to be negative but these Interactions can have either positive or negative effects on other parasites..
  • Cancer
  • Mental and emotional health problems
  • Opportunistic infections
  • Cardiovascular disease

Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.

FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.

Key Drivers: Virology Market

  • Early in 2016, the WHO officially issued a warning about the possible spread of zika virus to each Western Hemispheric region, as the disease vector Aedes aegypti was found to thrive strong in tropical and sub-tropical climatic conditions. This has been a key driver of market growth throughout 2016.
  • The virology market is constantly catering to the prevention and cure needs put forth by the healthcare sector; however, several diseases continue to demand R&D of novel applications, driving the growth of virology market. Various treatments and diagnostic processes also employ virology applications, further fuelling the market growth.
  • Burgeoning applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology is another factor fostering the overall growth of the virology market.
  • Moreover, the field of virology is extending in various forms, including molecular virology, paediatric virology, computational virology, and many more, prompting at increasing research findings throughout the forecast period. Research prospects are high and FMI indicates a continuing need for trained virologists in the near future.
  • Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also a key factor increasing public awareness and eventually influencing the market.

Key Restraints to Market Growth:

Maintaining the quality and safety standards of viral a controlling therapy has been a longstanding challenge, which is anticipated to hamper the market in the forecast period as well. Moreover, stringent approval processes for antiviral drugs is also foreseen to be a restraint to market growth. Another factor identified for affecting the market growth includes resistance toward and side effects of antiviral drugs for new treatment options.

Current Trends in the Virology Field:

In 2015, the virology industry was predominantly influenced by ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with better prospects in the near future.

Virologists are persistently investigating novel applications for viruses. Currently, an on-going research is experimenting on the exploitation of viruses for plant production, aiming at the efficient production of high quality, eco-friendly food.

Global Virology Market: Competitive Landscape:

By 2017 end, a few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. Following expiry of these blockbuster drugs, the market is estimated to discover a dynamic competitive landscape. The generic competition in the virology market will be at a high pace 2017 onward.  

Apart from expiring drugs, the market also has some late stage pipeline drugs, including Inavir, Elvitegravir, Vicriviroc, Rilpivirine, and Rapiacta. These drugs are set to enter the global market, fostering the competition globally.

Regional Outlook: Global Virology Market:

North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.

Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.

Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.

Segment-wise Market Forecast:

Immunoprophylaxis therapy and antiviral drugs are the fastest-growing market segments in the estimated forecast period.

STDs, urinary tract infections, and respiratory tract infections are currently dominating compared to other application types in the global virology market.

On the basis of diagnosis tests, hepatitis B, hepatitis C, HIV, human papillomavirus (HPV), and other tests (influenza, ebola, and dengue) are estimated to attract the largest market shares globally.

Hospitals and laboratories projected to continue the most dominating end-use segments, accounting for almost 50% market share globally.

Key Players in the Global Virology Market:

The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.

Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer's, ebola, and HIV. The company also has many other candidates, which are currently under review.

Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and application.

Market Research and Market Trends of virology market

  • Notable advances in nanotechnology, nanostructure-based electrical sensors have been emerged as promising platforms for real-time, sensitive detection of numerous bioanalytes. Using Nano pore-Based Resistive-Pulse Sensing Techniques, scientists are determining both the dimensions and the number of viruses. So, this provides important complementary information and detects all viruses and virus related particles.
  • Microbiology testing considered as one of the most rapidly growing segments in the diagnostics industry. The major driving forces for this include continuous spread of HIV, which is the world's major health threat and is a key factor contributing to the rise in opportunistic infections, bioterrorism, advances in molecular diagnostic technologies, and a wider availability of immune suppressive drug.
  • Awareness programs about various viruses such as Ebola virus, Flu, Zika virus, STD’s, AIDS are the key factor increasing people awareness and eventually increasing the market growth by employing the virology applications.

International Conference on Virology and Immunology helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in science and medicine.

We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company.

If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3million hits a month on our website, we have engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains. We maintain high quality and ethical standards of publication industry, which make us unique and better than the rest.

Our attendees can be your upcoming customers. If you sell research materials, recycling products, chemicals or relevant equipment or services, here is the opportunity to advertise in the website that can connect you to leading experts and science specialists worldwide.

Meetings International is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings International has been associated with national and international associations, corporations and high level individuals, dedicated to host world class conferences and events. Meetings International supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia, and industry.

Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

 For further queries, connect our conference manager at supports@meetings.com

 You can also connect us via What Sapp: +44 1792 680 005

                                                    Google Analytics Metrics of Virology 2022

The visitor’s traffic is the benchmark for the success of conference and Virology 2022 is constantly attracting viewers across the world.

According to the Google Analytics, more than 100+ monthly audiences are visiting to our conference websites for submitting abstracts; brochure downloads registration, exhibition and sponsorship queries.

Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.

                                                       Google Analytics Metrics of Meetings International

437,380 + Users

 1,606,987 + Page views

644,430 Sessions at the rate of 1.47 per user

Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers.
The promotion of the individual author contributions is taken care of and hence the authors enjoy the reputation among global audience. Meetings International values the contributions by the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving as well.

Meet Experts

Global Networking

Learning In a New Space

New Tips & Tactics

Certification